Invivyd (IVVD) Amortizatization of Intangibles (2021 - 2025)
Invivyd posted quarterly Amortizatization of Intangibles of $286000.0 for Q4 2025, down 33.8% year-on-year from $432000.0 in Q4 2024, and up 1.42% on a QoQ basis from $282000.0 in Q3 2025.
Invivyd (IVVD) has 5 years of Amortizatization of Intangibles data on file, last reported at $286000.0 in Q4 2025.
- For the quarter ending Q4 2025, Amortizatization of Intangibles fell 33.8% year-over-year to $286000.0; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (down 17.91% YoY), and the FY2025 full-year result was $1.4 million, down 17.91% from the prior year.
- Amortizatization of Intangibles for Q4 2025 stood at $286000.0, up from $282000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $4.2 million in Q2 2023 and bottomed at -$4.7 million in Q4 2023.
- The 5-year median for Amortizatization of Intangibles is $382500.0 (2023), against an average of $285555.6.
- Peak annual rise in Amortizatization of Intangibles reached 5358.06% in 2023, while the deepest fall reached 364.35% in 2023.
- A 5-year view of Amortizatization of Intangibles shows it stood at -$2.0 million in 2021, then soared by 188.74% to $1.8 million in 2022, then tumbled by 364.35% to -$4.7 million in 2023, then surged by 109.18% to $432000.0 in 2024, then slumped by 33.8% to $286000.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at $286000.0 (Q4 2025), $282000.0 (Q3 2025), and $352000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Invivyd | 208.38 Mn | -18.31 Mn | - | 286,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 286,000.00 |
| Dec 31, 2025 | 286,000.00 |
| Sep 30, 2025 | 282,000.00 |
| Sep 30, 2025 | 282,000.00 |
| Jun 30, 2025 | 352,000.00 |
| Jun 30, 2025 | 352,000.00 |
| Mar 31, 2025 | 432,000.00 |
| Mar 31, 2025 | 432,000.00 |
| Dec 31, 2024 | 432,000.00 |
| Dec 31, 2024 | 432,000.00 |
| Sep 30, 2024 | 427,000.00 |
| Sep 30, 2024 | 427,000.00 |
| Jun 30, 2024 | 386,000.00 |
| Jun 30, 2024 | 386,000.00 |
| Mar 31, 2024 | 402,000.00 |
| Mar 31, 2024 | 402,000.00 |
| Dec 31, 2023 | -4.71 Mn |
| Dec 31, 2023 | -4.71 Mn |
| Sep 30, 2023 | 1.69 Mn |
| Sep 30, 2023 | 1.69 Mn |
| Jun 30, 2023 | 4.19 Mn |
| Jun 30, 2023 | 4.19 Mn |
| Mar 31, 2023 | 379,000.00 |
| Mar 31, 2023 | 379,000.00 |
| Dec 31, 2022 | 1.78 Mn |
| Dec 31, 2022 | 1.78 Mn |
| Sep 30, 2022 | 31,000.00 |
| Sep 30, 2022 | 31,000.00 |
| Jun 30, 2022 | 131,000.00 |
| Jun 30, 2022 | 131,000.00 |
| Mar 31, 2022 | 80,000.00 |
| Mar 31, 2022 | 80,000.00 |
| Dec 31, 2021 | -2.01 Mn |
| Dec 31, 2021 | -2.01 Mn |
| Sep 30, 2021 | 577,000.00 |
| Sep 30, 2021 | 577,000.00 |